Polaryx Therapeutics (PLYX) vs Quantum Cyber N.V. (QUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Quantum Cyber N.V. is the larger company by market cap ($113.5 million vs $99.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PLYX | QUCY |
|---|---|---|
| Share price | $2.00 | $1.35 |
| Market cap | $99.69M | $113.49M |
| 1-day change | 0.00% | -2.88% |
| YTD return | — | +20.54% |
| 1-year return | — | -11.18% |
| EPS (TTM) | $-0.14 | $-2.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $48.91 | $4.93 |
| 52-week low | $1.85 | $0.30 |
| Distance from 52-week high | -95.91% | -72.62% |
| Analyst consensus | none | none |
| Avg. price target upside | +275.00% | +566.67% |
| Average volume | 76.41K | 691.24K |
| Shares outstanding | 49.85M | 84.07M |
| Employees | 2 | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Polaryx Therapeutics
PLYX stock →Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
PLYX vs QUCY FAQ
Which is bigger, Polaryx Therapeutics or Quantum Cyber N.V.?
Quantum Cyber N.V. (QUCY) is larger, with a market capitalization of $113.49M compared with $99.69M for Polaryx Therapeutics (PLYX).
Are Polaryx Therapeutics and Quantum Cyber N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.